

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | L-phenylalanine catabolic process (GO:0006559) | 7.53144606 |
| 2 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid catabolic process (GO:1902222) | 7.53144606 |
| 3 | L-phenylalanine metabolic process (GO:0006558) | 7.17970829 |
| 4 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid metabolic process (GO:1902221) | 7.17970829 |
| 5 | aromatic amino acid family catabolic process (GO:0009074) | 6.81403135 |
| 6 | triglyceride-rich lipoprotein particle remodeling (GO:0034370) | 6.31343415 |
| 7 | tryptophan catabolic process (GO:0006569) | 6.18817350 |
| 8 | indole-containing compound catabolic process (GO:0042436) | 6.18817350 |
| 9 | indolalkylamine catabolic process (GO:0046218) | 6.18817350 |
| 10 | kynurenine metabolic process (GO:0070189) | 5.97762057 |
| 11 | bile acid biosynthetic process (GO:0006699) | 5.91963832 |
| 12 | tryptophan metabolic process (GO:0006568) | 5.81907150 |
| 13 | glyoxylate metabolic process (GO:0046487) | 5.74300061 |
| 14 | alpha-linolenic acid metabolic process (GO:0036109) | 5.65899344 |
| 15 | high-density lipoprotein particle remodeling (GO:0034375) | 5.57223944 |
| 16 | urea metabolic process (GO:0019627) | 5.54399741 |
| 17 | urea cycle (GO:0000050) | 5.54399741 |
| 18 | negative regulation of fibrinolysis (GO:0051918) | 5.40943680 |
| 19 | sulfur amino acid catabolic process (GO:0000098) | 5.35485190 |
| 20 | cysteine metabolic process (GO:0006534) | 5.35019325 |
| 21 | protein carboxylation (GO:0018214) | 5.25416830 |
| 22 | peptidyl-glutamic acid carboxylation (GO:0017187) | 5.25416830 |
| 23 | regulation of fibrinolysis (GO:0051917) | 5.24838214 |
| 24 | complement activation, alternative pathway (GO:0006957) | 5.13872297 |
| 25 | nitrogen cycle metabolic process (GO:0071941) | 5.11010446 |
| 26 | serine family amino acid catabolic process (GO:0009071) | 5.10348320 |
| 27 | bile acid metabolic process (GO:0008206) | 5.09154920 |
| 28 | regulation of protein activation cascade (GO:2000257) | 5.06787726 |
| 29 | fatty acid beta-oxidation using acyl-CoA oxidase (GO:0033540) | 4.99072912 |
| 30 | regulation of cholesterol esterification (GO:0010872) | 4.95586338 |
| 31 | aromatic amino acid family metabolic process (GO:0009072) | 4.94286045 |
| 32 | proteasome assembly (GO:0043248) | 4.85663909 |
| 33 | reverse cholesterol transport (GO:0043691) | 4.85386507 |
| 34 | homocysteine metabolic process (GO:0050667) | 4.83946613 |
| 35 | regulation of triglyceride catabolic process (GO:0010896) | 4.79014837 |
| 36 | tyrosine metabolic process (GO:0006570) | 4.78168118 |
| 37 | protein-lipid complex remodeling (GO:0034368) | 4.77792220 |
| 38 | macromolecular complex remodeling (GO:0034367) | 4.77792220 |
| 39 | plasma lipoprotein particle remodeling (GO:0034369) | 4.77792220 |
| 40 | amino-acid betaine metabolic process (GO:0006577) | 4.69765263 |
| 41 | regulation of complement activation (GO:0030449) | 4.69495073 |
| 42 | alpha-amino acid catabolic process (GO:1901606) | 4.64129197 |
| 43 | phospholipid efflux (GO:0033700) | 4.59604127 |
| 44 | acylglycerol homeostasis (GO:0055090) | 4.56505497 |
| 45 | triglyceride homeostasis (GO:0070328) | 4.56505497 |
| 46 | lysine metabolic process (GO:0006553) | 4.54283923 |
| 47 | lysine catabolic process (GO:0006554) | 4.54283923 |
| 48 | negative regulation of cholesterol transport (GO:0032375) | 4.48148932 |
| 49 | negative regulation of sterol transport (GO:0032372) | 4.48148932 |
| 50 | cellular ketone body metabolic process (GO:0046950) | 4.43842997 |
| 51 | indolalkylamine metabolic process (GO:0006586) | 4.40406723 |
| 52 | plasma lipoprotein particle clearance (GO:0034381) | 4.37476667 |
| 53 | coenzyme catabolic process (GO:0009109) | 4.37358133 |
| 54 | amine catabolic process (GO:0009310) | 4.37119689 |
| 55 | cellular biogenic amine catabolic process (GO:0042402) | 4.37119689 |
| 56 | bile acid and bile salt transport (GO:0015721) | 4.35147465 |
| 57 | imidazole-containing compound metabolic process (GO:0052803) | 4.34393469 |
| 58 | glycine metabolic process (GO:0006544) | 4.33345659 |
| 59 | cellular amino acid catabolic process (GO:0009063) | 4.27678420 |
| 60 | cellular glucuronidation (GO:0052695) | 4.27287155 |
| 61 | cholesterol efflux (GO:0033344) | 4.21219251 |
| 62 | low-density lipoprotein particle remodeling (GO:0034374) | 4.18735111 |
| 63 | serine family amino acid metabolic process (GO:0009069) | 4.15043682 |
| 64 | glutamate metabolic process (GO:0006536) | 4.13840505 |
| 65 | benzene-containing compound metabolic process (GO:0042537) | 4.12769171 |
| 66 | ethanol oxidation (GO:0006069) | 4.07520849 |
| 67 | establishment of integrated proviral latency (GO:0075713) | 4.03722425 |
| 68 | plasma lipoprotein particle assembly (GO:0034377) | 4.03405792 |
| 69 | serine family amino acid biosynthetic process (GO:0009070) | 4.02466919 |
| 70 | negative regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle (GO:0051436) | 4.02386699 |
| 71 | purine nucleobase biosynthetic process (GO:0009113) | 4.00556933 |
| 72 | cellular modified amino acid catabolic process (GO:0042219) | 4.00460715 |
| 73 | aldehyde catabolic process (GO:0046185) | 4.00223403 |
| 74 | CENP-A containing nucleosome assembly (GO:0034080) | 3.97854146 |
| 75 | arginine metabolic process (GO:0006525) | 3.94161418 |
| 76 | ribosome assembly (GO:0042255) | 3.92597687 |
| 77 | chromatin remodeling at centromere (GO:0031055) | 3.92511841 |
| 78 | regulation of mitotic cell cycle spindle assembly checkpoint (GO:0090266) | 3.89886644 |
| 79 | regulation of mitotic spindle checkpoint (GO:1903504) | 3.89886644 |
| 80 | drug catabolic process (GO:0042737) | 3.89804640 |
| 81 | fibrinolysis (GO:0042730) | 3.89400495 |
| 82 | dicarboxylic acid biosynthetic process (GO:0043650) | 3.88634378 |
| 83 | regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle (GO:0051439) | 3.88321200 |
| 84 | ketone body metabolic process (GO:1902224) | 3.84114856 |
| 85 | cofactor catabolic process (GO:0051187) | 3.82198390 |
| 86 | very-low-density lipoprotein particle assembly (GO:0034379) | 3.81792451 |
| 87 | short-chain fatty acid metabolic process (GO:0046459) | 3.81609947 |
| 88 | negative regulation of lipase activity (GO:0060192) | 3.81176082 |
| 89 | glucuronate metabolic process (GO:0019585) | 3.80717145 |
| 90 | uronic acid metabolic process (GO:0006063) | 3.80717145 |
| 91 | IMP biosynthetic process (GO:0006188) | 3.79980909 |
| 92 | blood coagulation, intrinsic pathway (GO:0007597) | 3.78682639 |
| 93 | * carboxylic acid catabolic process (GO:0046395) | 3.77663086 |
| 94 | * organic acid catabolic process (GO:0016054) | 3.77663086 |
| 95 | positive regulation of triglyceride lipase activity (GO:0061365) | 3.73904690 |
| 96 | positive regulation of lipoprotein lipase activity (GO:0051006) | 3.73904690 |
| 97 | positive regulation of lipid catabolic process (GO:0050996) | 3.73179624 |
| 98 | DNA ligation (GO:0006266) | 3.72959159 |
| 99 | phospholipid homeostasis (GO:0055091) | 3.72916755 |
| 100 | acetyl-CoA metabolic process (GO:0006084) | 3.72246989 |
| 101 | cholesterol homeostasis (GO:0042632) | 3.71488407 |
| 102 | positive regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle (GO:0051437) | 3.70426441 |
| 103 | negative regulation of ubiquitin-protein transferase activity (GO:0051444) | 3.69862212 |
| 104 | negative regulation of ligase activity (GO:0051352) | 3.69862212 |
| 105 | DNA strand elongation involved in DNA replication (GO:0006271) | 3.66541333 |
| 106 | anaphase-promoting complex-dependent proteasomal ubiquitin-dependent protein catabolic process (GO:0 | 3.66462100 |
| 107 | regulation of bile acid biosynthetic process (GO:0070857) | 3.65959006 |
| 108 | plasma lipoprotein particle organization (GO:0071827) | 3.65895692 |
| 109 | sterol homeostasis (GO:0055092) | 3.64933381 |
| 110 | NAD biosynthetic process (GO:0009435) | 3.62481841 |
| 111 | protein activation cascade (GO:0072376) | 3.62070582 |
| 112 | complement activation (GO:0006956) | 3.59427587 |
| 113 | protein-lipid complex assembly (GO:0065005) | 3.58870328 |
| 114 | pyridine nucleotide biosynthetic process (GO:0019363) | 3.58652923 |
| 115 | nicotinamide nucleotide biosynthetic process (GO:0019359) | 3.58652923 |
| 116 | complement activation, classical pathway (GO:0006958) | 3.57578275 |
| 117 | nucleobase biosynthetic process (GO:0046112) | 3.54889939 |
| 118 | opsonization (GO:0008228) | 3.52649285 |
| 119 | regulation of cellular amino acid metabolic process (GO:0006521) | 3.49489846 |
| 120 | cullin deneddylation (GO:0010388) | 3.49126238 |
| 121 | DNA strand elongation (GO:0022616) | 3.49109682 |
| 122 | protein deneddylation (GO:0000338) | 3.42106752 |
| 123 | L-serine metabolic process (GO:0006563) | 3.41330818 |
| 124 | rRNA modification (GO:0000154) | 3.40899063 |
| 125 | telomere maintenance via semi-conservative replication (GO:0032201) | 3.39470002 |
| 126 | IMP metabolic process (GO:0046040) | 3.36516208 |
| 127 | histone exchange (GO:0043486) | 3.35764308 |
| 128 | mitochondrial ATP synthesis coupled proton transport (GO:0042776) | 3.25862711 |
| 129 | RNA splicing, via endonucleolytic cleavage and ligation (GO:0000394) | 3.25389184 |
| 130 | tRNA splicing, via endonucleolytic cleavage and ligation (GO:0006388) | 3.25389184 |
| 131 | DNA replication checkpoint (GO:0000076) | 3.21139991 |
| 132 | chaperone-mediated protein transport (GO:0072321) | 3.21056917 |
| 133 | signal transduction involved in mitotic DNA damage checkpoint (GO:1902402) | 3.18276291 |
| 134 | signal transduction involved in mitotic cell cycle checkpoint (GO:0072413) | 3.18276291 |
| 135 | signal transduction involved in mitotic DNA integrity checkpoint (GO:1902403) | 3.18276291 |
| 136 | positive regulation of ubiquitin-protein transferase activity (GO:0051443) | 3.17532557 |
| 137 | establishment of viral latency (GO:0019043) | 3.17198484 |
| 138 | DNA damage response, signal transduction by p53 class mediator resulting in cell cycle arrest (GO:00 | 3.17036599 |
| 139 | exonucleolytic nuclear-transcribed mRNA catabolic process involved in deadenylation-dependent decay | 3.16673943 |
| 140 | positive regulation of ligase activity (GO:0051351) | 3.14241991 |
| 141 | intracellular signal transduction involved in G1 DNA damage checkpoint (GO:1902400) | 3.13979722 |
| 142 | signal transduction involved in mitotic G1 DNA damage checkpoint (GO:0072431) | 3.13979722 |
| 143 | nuclear-transcribed mRNA catabolic process, exonucleolytic (GO:0000291) | 3.11790415 |
| 144 | DNA double-strand break processing (GO:0000729) | 3.11747768 |
| 145 | branched-chain amino acid catabolic process (GO:0009083) | 3.11023683 |
| 146 | mitotic metaphase plate congression (GO:0007080) | 3.10679705 |
| 147 | signal transduction involved in DNA integrity checkpoint (GO:0072401) | 3.08391608 |
| 148 | signal transduction involved in DNA damage checkpoint (GO:0072422) | 3.08391608 |
| 149 | protein localization to kinetochore (GO:0034501) | 3.07683060 |
| 150 | double-strand break repair via nonhomologous end joining (GO:0006303) | 3.05380072 |
| 151 | non-recombinational repair (GO:0000726) | 3.05380072 |
| 152 | DNA replication-independent nucleosome assembly (GO:0006336) | 3.04605691 |
| 153 | DNA replication-independent nucleosome organization (GO:0034724) | 3.04605691 |
| 154 | signal transduction involved in cell cycle checkpoint (GO:0072395) | 3.04249933 |
| 155 | establishment of protein localization to mitochondrial membrane (GO:0090151) | 3.03582276 |
| 156 | rRNA methylation (GO:0031167) | 3.03046221 |
| 157 | negative regulation of mitotic sister chromatid separation (GO:2000816) | 3.01975807 |
| 158 | negative regulation of sister chromatid segregation (GO:0033046) | 3.01975807 |
| 159 | negative regulation of mitotic metaphase/anaphase transition (GO:0045841) | 3.01975807 |
| 160 | negative regulation of metaphase/anaphase transition of cell cycle (GO:1902100) | 3.01975807 |
| 161 | negative regulation of mitotic sister chromatid segregation (GO:0033048) | 3.01975807 |
| 162 | regulation of ubiquitin-protein transferase activity (GO:0051438) | 3.01202487 |
| 163 | kinetochore organization (GO:0051383) | 2.99237876 |
| 164 | regulation of ligase activity (GO:0051340) | 2.99167056 |
| 165 | spindle checkpoint (GO:0031577) | 2.97171977 |
| 166 | somatic hypermutation of immunoglobulin genes (GO:0016446) | 2.96924328 |
| 167 | somatic diversification of immune receptors via somatic mutation (GO:0002566) | 2.96924328 |
| 168 | mitotic recombination (GO:0006312) | 2.95980201 |
| 169 | mitotic spindle checkpoint (GO:0071174) | 2.95281413 |
| 170 | amino acid activation (GO:0043038) | 2.94994370 |
| 171 | tRNA aminoacylation (GO:0043039) | 2.94994370 |
| 172 | tRNA aminoacylation for protein translation (GO:0006418) | 2.94790755 |
| 173 | transcription elongation from RNA polymerase III promoter (GO:0006385) | 2.94674386 |
| 174 | termination of RNA polymerase III transcription (GO:0006386) | 2.94674386 |
| 175 | negative regulation of chromosome segregation (GO:0051985) | 2.94631891 |
| 176 | telomere maintenance via recombination (GO:0000722) | 2.93164743 |
| 177 | formation of translation preinitiation complex (GO:0001731) | 2.93125307 |
| 178 | folic acid-containing compound biosynthetic process (GO:0009396) | 2.91970567 |
| 179 | water-soluble vitamin biosynthetic process (GO:0042364) | 2.91686015 |
| 180 | somatic recombination of immunoglobulin genes involved in immune response (GO:0002204) | 2.90788712 |
| 181 | somatic diversification of immunoglobulins involved in immune response (GO:0002208) | 2.90788712 |
| 182 | isotype switching (GO:0045190) | 2.90788712 |
| 183 | mitochondrial RNA metabolic process (GO:0000959) | 2.90457454 |
| 184 | oxidative phosphorylation (GO:0006119) | 2.90446471 |
| 185 | kinetochore assembly (GO:0051382) | 2.89887470 |
| 186 | metaphase plate congression (GO:0051310) | 2.88782818 |
| 187 | pseudouridine synthesis (GO:0001522) | 2.88725079 |
| 188 | regulation of mitochondrial translation (GO:0070129) | 2.88718151 |
| 189 | DNA replication-dependent nucleosome organization (GO:0034723) | 2.88695250 |
| 190 | DNA replication-dependent nucleosome assembly (GO:0006335) | 2.88695250 |
| 191 | regulation of helicase activity (GO:0051095) | 2.87852217 |
| 192 | L-methionine salvage (GO:0071267) | 2.86307085 |
| 193 | L-methionine biosynthetic process (GO:0071265) | 2.86307085 |
| 194 | amino acid salvage (GO:0043102) | 2.86307085 |
| 195 | tricarboxylic acid cycle (GO:0006099) | 2.84028643 |
| 196 | respiratory chain complex IV assembly (GO:0008535) | 2.81487401 |
| 197 | negative regulation of DNA-dependent DNA replication (GO:2000104) | 2.80821004 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | * RXR_22158963_ChIP-Seq_LIVER_Mouse | 8.31075000 |
| 2 | EGR1_23403033_ChIP-Seq_LIVER_Mouse | 7.14204796 |
| 3 | PPARA_22158963_ChIP-Seq_LIVER_Mouse | 7.09351765 |
| 4 | LXR_22158963_ChIP-Seq_LIVER_Mouse | 6.48485561 |
| 5 | E2F7_22180533_ChIP-Seq_HELA_Human | 5.75049711 |
| 6 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 5.24193445 |
| 7 | CEBPA_23403033_ChIP-Seq_LIVER_Mouse | 5.18728439 |
| 8 | KDM6A_18722178_ChIP-ChIP_U937_AND_SAOS2_Human | 4.97405910 |
| 9 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 4.86659407 |
| 10 | CEBPB_23403033_ChIP-Seq_LIVER_Mouse | 4.06905846 |
| 11 | NR1I2_20693526_ChIP-Seq_LIVER_Mouse | 3.93858358 |
| 12 | GABP_17652178_ChIP-ChIP_JURKAT_Human | 3.89135244 |
| 13 | EST1_17652178_ChIP-ChIP_JURKAT_Human | 3.68801645 |
| 14 | E2F4_17652178_ChIP-ChIP_JURKAT_Human | 3.50148612 |
| 15 | MYC_18555785_ChIP-Seq_MESCs_Mouse | 3.21573278 |
| 16 | CREB1_15753290_ChIP-ChIP_HEK293T_Human | 3.15182137 |
| 17 | JARID1A_20064375_ChIP-Seq_MESCs_Mouse | 3.13334425 |
| 18 | NOTCH1_17114293_ChIP-ChIP_T-ALL_Human | 3.03513185 |
| 19 | CHD1_19587682_ChIP-ChIP_MESCs_Mouse | 2.86701584 |
| 20 | ELF1_17652178_ChIP-ChIP_JURKAT_Human | 2.86279464 |
| 21 | ETS1_20019798_ChIP-Seq_JURKAT_Human | 2.75763007 |
| 22 | EKLF_21900194_ChIP-Seq_ERYTHROCYTE_Mouse | 2.59684625 |
| 23 | ELK1_19687146_ChIP-ChIP_HELA_Human | 2.59583214 |
| 24 | * FOXM1_25889361_ChIP-Seq_OE33_AND_U2OS_Human | 2.56190174 |
| 25 | VDR_23849224_ChIP-Seq_CD4+_Human | 2.52029851 |
| 26 | HOXC9_25013753_ChIP-Seq_NEUROBLASTOMA_BE2-C_Human | 2.46193163 |
| 27 | FOXP3_21729870_ChIP-Seq_TREG_Human | 2.40756303 |
| 28 | HCFC1_20581084_ChIP-Seq_MESCs_Mouse | 2.40637505 |
| 29 | MYC_19030024_ChIP-ChIP_MESCs_Mouse | 2.39010188 |
| 30 | MYC_18358816_ChIP-ChIP_MESCs_Mouse | 2.38126115 |
| 31 | MYCN_21190229_ChIP-Seq_SHEP-21N_Human | 2.33806999 |
| 32 | PPARG_23326641_ChIP-Seq_C3H10T1-2_Mouse | 2.24801941 |
| 33 | SRF_21415370_ChIP-Seq_HL-1_Mouse | 2.21600074 |
| 34 | NELFA_20434984_ChIP-Seq_ESCs_Mouse | 2.06382329 |
| 35 | FOXO3_22982991_ChIP-Seq_MACROPHAGES_Mouse | 2.04775545 |
| 36 | FOXM1_23109430_ChIP-Seq_U2OS_Human | 2.04299355 |
| 37 | TCF7L2_21901280_ChIP-Seq_H4IIE_Rat | 2.04239353 |
| 38 | E2F1_18555785_ChIP-Seq_MESCs_Mouse | 2.03188247 |
| 39 | MYC_19079543_ChIP-ChIP_MESCs_Mouse | 2.02552244 |
| 40 | HOXA2_22223247_ChIP-Seq_E11.5_EMBRYO_Mouse | 2.02540701 |
| 41 | DCP1A_22483619_ChIP-Seq_HELA_Human | 2.01677176 |
| 42 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 11.7880809 |
| 43 | TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.97719066 |
| 44 | HNF4A_19761587_ChIP-ChIP_CACO-2_Human | 1.96814388 |
| 45 | * PADI4_21655091_ChIP-ChIP_MCF-7_Human | 1.95253043 |
| 46 | HOXB4_20404135_ChIP-ChIP_EML_Mouse | 1.94042748 |
| 47 | THAP11_20581084_ChIP-Seq_MESCs_Mouse | 1.85871404 |
| 48 | * PDX1_19855005_ChIP-ChIP_MIN6_Mouse | 1.73445240 |
| 49 | MYCN_18555785_ChIP-Seq_MESCs_Mouse | 1.72082374 |
| 50 | GABP_19822575_ChIP-Seq_HepG2_Human | 1.70579393 |
| 51 | YY1_23942234_ChIP-Seq_MYOBLASTS_AND_MYOTUBES_Mouse | 1.69192188 |
| 52 | KDM5B_21448134_ChIP-Seq_MESCs_Mouse | 1.67167183 |
| 53 | HTT_18923047_ChIP-ChIP_STHdh_Human | 1.66227753 |
| 54 | ZFP42_18358816_ChIP-ChIP_MESCs_Mouse | 1.64094705 |
| 55 | E2F1_21310950_ChIP-Seq_MCF-7_Human | 1.61028857 |
| 56 | SALL1_21062744_ChIP-ChIP_HESCs_Human | 1.59211243 |
| 57 | TTF2_22483619_ChIP-Seq_HELA_Human | 1.57161799 |
| 58 | * FOXA2_19822575_ChIP-Seq_HepG2_Human | 1.55358200 |
| 59 | AR_21909140_ChIP-Seq_LNCAP_Human | 1.53279973 |
| 60 | * XRN2_22483619_ChIP-Seq_HELA_Human | 1.52781022 |
| 61 | MYC_18940864_ChIP-ChIP_HL60_Human | 1.51329942 |
| 62 | GATA1_22025678_ChIP-Seq_K562_Human | 1.49596665 |
| 63 | MYBL2_22936984_ChIP-ChIP_MESCs_Mouse | 1.47464239 |
| 64 | MYBL1_21750041_ChIP-ChIP_SPERMATOCYTES_Mouse | 1.46251924 |
| 65 | CLOCK_20551151_ChIP-Seq_293T_Human | 1.42692365 |
| 66 | CIITA_18437201_ChIP-ChIP_Raji_B_and_iDC_Human | 1.42568927 |
| 67 | SPI1_22790984_ChIP-Seq_ERYTHROLEUKEMIA_Mouse | 1.37630088 |
| 68 | * HNF4A_19822575_ChIP-Seq_HepG2_Human | 1.37471307 |
| 69 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 1.33086167 |
| 70 | POU5F1_18555785_ChIP-Seq_MESCs_Mouse | 1.32245761 |
| 71 | YY1_21170310_ChIP-Seq_MESCs_Mouse | 1.31417516 |
| 72 | ZFX_18555785_ChIP-Seq_MESCs_Mouse | 1.29550968 |
| 73 | PRDM5_23873026_ChIP-Seq_MEFs_Mouse | 1.29179921 |
| 74 | SOX9_22984422_ChIP-ChIP_TESTIS_Rat | 1.19477923 |
| 75 | RXRA_24833708_ChIP-Seq_LIVER_Mouse | 1.18711750 |
| 76 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 1.16856219 |
| 77 | KDM5A_27292631_Chip-Seq_BREAST_Human | 1.14278542 |
| 78 | ASH2L_23239880_ChIP-Seq_MESCs_Mouse | 1.13969851 |
| 79 | ERG_20887958_ChIP-Seq_HPC-7_Mouse | 1.13645067 |
| 80 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 1.13601176 |
| 81 | NANOG_16153702_ChIP-ChIP_HESCs_Human | 1.11877678 |
| 82 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 1.11163035 |
| 83 | FLI1_27457419_Chip-Seq_LIVER_Mouse | 1.11067423 |
| 84 | POU5F1_18358816_ChIP-ChIP_MESCs_Mouse | 1.10333337 |
| 85 | E2F4_21247883_ChIP-Seq_LYMPHOBLASTOID_Human | 1.09630398 |
| 86 | EWS_26573619_Chip-Seq_HEK293_Human | 1.08887105 |
| 87 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 1.08655533 |
| 88 | NANOG_18555785_ChIP-Seq_MESCs_Mouse | 1.06395458 |
| 89 | BCL3_23251550_ChIP-Seq_MUSCLE_Mouse | 1.02559494 |
| 90 | FOXP1_22492998_ChIP-Seq_STRATIUM_Mouse | 1.01649065 |
| 91 | FUS_26573619_Chip-Seq_HEK293_Human | 1.01043952 |
| 92 | PRDM16_22522345_ChIP-ChIP_PALATE_MESENCHYMAL_Mouse | 1.00481662 |
| 93 | FLI1_20887958_ChIP-Seq_HPC-7_Mouse | 0.99423706 |
| 94 | PPARD_23176727_ChIP-Seq_KERATINOCYTES_Mouse | 0.98617264 |
| 95 | CUX1_19635798_ChIP-ChIP_MULTIPLE_HUMAN_CANCER_TYPES_Human | 0.98029911 |
| 96 | ETS2_20176728_ChIP-ChIP_TROPHOBLAST_STEM_CELLS_Mouse | 0.97709573 |
| 97 | TFEB_21752829_ChIP-Seq_HELA_Human | 0.97494366 |
| 98 | ZNF274_21170338_ChIP-Seq_K562_Hela | 0.95111048 |
| 99 | NOTCH1_21737748_ChIP-Seq_TLL_Human | 0.94749897 |
| 100 | SOX2_16153702_ChIP-ChIP_HESCs_Human | 0.94631750 |
| 101 | CIITA_25753668_ChIP-Seq_RAJI_Human | 0.93743440 |
| 102 | TRP63_18441228_ChIP-ChIP_KERATINOCYTES_Mouse | 0.92315100 |
| 103 | KAP1_22055183_ChIP-Seq_ESCs_Mouse | 0.88685823 |
| 104 | SOX17_20123909_ChIP-Seq_XEN_Mouse | 0.88104485 |
| 105 | TAL1_20887958_ChIP-Seq_HPC-7_Mouse | 0.88038306 |
| 106 | SOX2_27498859_Chip-Seq_STOMACH_Mouse | 0.86649210 |
| 107 | SFPI1_20887958_ChIP-Seq_HPC-7_Mouse | 0.84410125 |
| 108 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 0.83933310 |
| 109 | AUTS2_25519132_ChIP-Seq_293T-REX_Human | 0.83246358 |
| 110 | POU3F2_20337985_ChIP-ChIP_501MEL_Human | 0.83059234 |
| 111 | ZNF652_21678463_ChIP-ChIP_ZR75-1_Human | 0.82575855 |
| 112 | GATA4_25053715_ChIP-Seq_YYC3_Human | 0.80841937 |
| 113 | ELK1_22589737_ChIP-Seq_MCF10A_Human | 0.80795056 |
| 114 | POU5F1_16153702_ChIP-ChIP_HESCs_Human | 0.79294147 |
| 115 | NANOG_18358816_ChIP-ChIP_MESCs_Mouse | 0.78597564 |
| 116 | ESR1_15608294_ChIP-ChIP_MCF-7_Human | 0.77614685 |
| 117 | E4F1_26484288_ChIP-Seq_MOUSE_EMBRYONIC_FIBROBLAST_Mouse | 0.76484346 |
| 118 | BACH1_22875853_ChIP-PCR_HELA_AND_SCP4_Human | 0.76414984 |
| 119 | DMRT1_21621532_ChIP-ChIP_FETAL_Ovary | 0.75907784 |
| 120 | SOX2_18555785_ChIP-Seq_MESCs_Mouse | 0.74022662 |
| 121 | CREM_20920259_ChIP-Seq_GC1-SPG_Mouse | 0.73995452 |
| 122 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 0.73897344 |
| 123 | PCGF2_27294783_Chip-Seq_ESCs_Mouse | 0.72944957 |
| 124 | ASXL1_24218140_ChIP-Seq_BMDM_Mouse | 0.72811274 |
| 125 | SREBP2_21459322_ChIP-Seq_LIVER_Mouse | 0.71735757 |
| 126 | GFI1B_20887958_ChIP-Seq_HPC-7_Mouse | 0.71724590 |
| 127 | NFE2L2_20460467_ChIP-Seq_MEFs_Mouse | 0.71598043 |
| 128 | NRF2_20460467_ChIP-Seq_MEFs_Mouse | 0.71598043 |
| 129 | CEBPB_21427703_ChIP-Seq_3T3-L1_Mouse | 0.71268822 |
| 130 | SREBP1_19666523_ChIP-Seq_LIVER_Mouse | 0.70801465 |
| 131 | RARA_24833708_ChIP-Seq_LIVER_Mouse | 0.70407242 |
| 132 | CCND1_20090754_ChIP-ChIP_RETINA_Mouse | 0.70086145 |
| 133 | VDR_22108803_ChIP-Seq_LS180_Human | 0.69887461 |
| 134 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 0.68242844 |
| 135 | AR_21915096_ChIP-Seq_LNCaP-1F5_Human | 0.66774884 |
| 136 | CNOT3_19339689_ChIP-ChIP_MESCs_Mouse | 0.66216042 |
| 137 | ELF5_23300383_ChIP-Seq_T47D_Human | 0.65553803 |
| 138 | SALL4_18804426_ChIP-ChIP_XEN_Mouse | 0.65160320 |
| 139 | SALL4_22934838_ChIP-ChIP_CD34+_Human | 0.64391542 |
| 140 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 0.63107483 |
| 141 | ESRRB_18555785_ChIP-Seq_MESCs_Mouse | 0.62412020 |
| 142 | BMI1_19503595_ChIP-Seq_MEFsC_Mouse | 0.62284849 |
| 143 | AR_20517297_ChIP-Seq_VCAP_Human | 0.61963031 |
| 144 | * RAD21_21589869_ChIP-Seq_MESCs_Mouse | 0.60333148 |
| 145 | RARB_24833708_ChIP-Seq_LIVER_Mouse | 0.59830554 |
| 146 | CEBPB_22108803_ChIP-Seq_LS180_Human | 0.59674503 |
| 147 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 0.58663151 |
| 148 | STAT1_17558387_ChIP-Seq_HELA_Human | 0.57697948 |
| 149 | TAF15_26573619_Chip-Seq_HEK293_Human | 0.56725188 |
| 150 | PBX_27287812_Chip-Seq_EMBYONIC-LIMB_Mouse | 0.55712818 |
| 151 | NR4A2_19515692_ChIP-ChIP_MN9D_Mouse | 0.55149643 |
| 152 | EGR1_19032775_ChIP-ChIP_M12_Human | 0.54962782 |
| 153 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 0.54868694 |
| 154 | CDX2_21402776_ChIP-Seq_INTESTINAL-VILLUS_Mouse | 0.53721531 |
| 155 | * PPARG_20887899_ChIP-Seq_3T3-L1_Mouse | 0.53289927 |
| 156 | ESET_19884257_ChIP-Seq_ESCs_Mouse | 0.53039725 |
| 157 | * FOXA1_21915096_ChIP-Seq_LNCaP-1F5_Human | 0.52829069 |
| 158 | CBP_21632823_ChIP-Seq_H3396_Human | 0.52710936 |
| 159 | * FOXA1_25552417_ChIP-Seq_VCAP_Human | 0.51492175 |
| 160 | MYC_19915707_ChIP-ChIP_AK7_Human | 0.51326828 |
| 161 | SOX6_21985497_ChIP-Seq_MYOTUBES_Mouse | 0.49467655 |
| 162 | FOXA1_26743006_Chip-Seq_LNCaP-abl_Human | 0.48912016 |
| 163 | NR0B1_18358816_ChIP-ChIP_MESCs_Mouse | 0.47858441 |
| 164 | PBX1_22567123_ChIP-ChIP_OVCAR3_Human | 0.47140193 |
| 165 | P53_21459846_ChIP-Seq_SAOS-2_Human | 0.46409712 |
| 166 | ESR1_20079471_ChIP-ChIP_T-47D_Human | 0.45089869 |
| 167 | BCAT_22108803_ChIP-Seq_LS180_Human | 0.44815030 |
| 168 | PPARD_23208498_ChIP-Seq_MDA-MB-231_Human | 0.44810604 |
| 169 | IRF1_19129219_ChIP-ChIP_H3396_Human | 0.44358435 |
| 170 | CRX_20693478_ChIP-Seq_RETINA_Mouse | 0.43965831 |
| 171 | EZH2_27294783_Chip-Seq_NPCs_Mouse | 0.42895395 |
| 172 | CDX2_20551321_ChIP-Seq_CACO-2_Human | 0.42637898 |
| 173 | GATA1_19941826_ChIP-Seq_K562_Human | 0.42399500 |
| 174 | GATA1_19941827_ChIP-Seq_MEL_Mouse | 0.42378465 |
| 175 | EWS-FLI1_20517297_ChIP-Seq_SK-N-MC_Human | 0.42072655 |
| 176 | OCT4_21477851_ChIP-Seq_ESCs_Mouse | 0.41699518 |
| 177 | TAF2_19829295_ChIP-Seq_ESCs_Human | 0.41423454 |
| 178 | GATA2_19941826_ChIP-Seq_K562_Human | 0.40936272 |
| 179 | ESR1_21235772_ChIP-Seq_MCF-7_Human | 0.40822914 |
| 180 | GATA2_20887958_ChIP-Seq_HPC-7_Mouse | 0.39629238 |
| 181 | CDX2_22108803_ChIP-Seq_LS180_Human | 0.39566201 |
| 182 | FOXA1_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.39559936 |
| 183 | STAT3_1855785_ChIP-Seq_MESCs_Mouse | 0.38869289 |
| 184 | NFE2_27457419_Chip-Seq_LIVER_Mouse | 0.38501784 |
| 185 | PPAR_26484153_Chip-Seq_NCI-H1993_Human | 0.37896437 |
| 186 | FOXH1_21741376_ChIP-Seq_EPCs_Human | 0.37076891 |
| 187 | FOXA1_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 0.35757843 |
| 188 | SUZ12_27294783_Chip-Seq_NPCs_Mouse | 0.35433603 |
| 189 | * SRY_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 0.35309647 |
| 190 | FOXO3_23340844_ChIP-Seq_DLD1_Human | 0.35271653 |
| 191 | BCL11B_21912641_ChIP-Seq_STHDH_STRIUM_Mouse | 0.34990723 |
| 192 | NCOR_22424771_ChIP-Seq_293T_Human | 0.34964088 |
| 193 | RUNX1_27457419_Chip-Seq_LIVER_Mouse | 0.34780716 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0002139_abnormal_hepatobiliary_system | 8.28866787 |
| 2 | MP0005360_urolithiasis | 7.46173264 |
| 3 | MP0005085_abnormal_gallbladder_physiolo | 6.35959893 |
| 4 | MP0005365_abnormal_bile_salt | 6.19924069 |
| 5 | MP0008875_abnormal_xenobiotic_pharmacok | 5.11206030 |
| 6 | MP0008058_abnormal_DNA_repair | 4.39519668 |
| 7 | MP0003806_abnormal_nucleotide_metabolis | 4.26814633 |
| 8 | MP0003693_abnormal_embryo_hatching | 4.21731631 |
| 9 | MP0010094_abnormal_chromosome_stability | 4.20773555 |
| 10 | MP0003252_abnormal_bile_duct | 3.88531763 |
| 11 | MP0010329_abnormal_lipoprotein_level | 3.56726617 |
| 12 | MP0004957_abnormal_blastocyst_morpholog | 3.53000364 |
| 13 | MP0003111_abnormal_nucleus_morphology | 3.33093873 |
| 14 | MP0009840_abnormal_foam_cell | 3.24757090 |
| 15 | MP0005083_abnormal_biliary_tract | 3.06209965 |
| 16 | MP0003195_calcinosis | 2.93795064 |
| 17 | MP0003077_abnormal_cell_cycle | 2.93358180 |
| 18 | MP0005332_abnormal_amino_acid | 2.81903169 |
| 19 | MP0008877_abnormal_DNA_methylation | 2.80734963 |
| 20 | MP0008007_abnormal_cellular_replicative | 2.74292806 |
| 21 | MP0003786_premature_aging | 2.54272228 |
| 22 | MP0001666_abnormal_nutrient_absorption | 2.53787528 |
| 23 | MP0008932_abnormal_embryonic_tissue | 2.39840368 |
| 24 | MP0003191_abnormal_cellular_cholesterol | 2.33033489 |
| 25 | MP0003941_abnormal_skin_development | 2.24134086 |
| 26 | MP0004019_abnormal_vitamin_homeostasis | 2.23766571 |
| 27 | MP0000609_abnormal_liver_physiology | 2.14256184 |
| 28 | MP0002118_abnormal_lipid_homeostasis | 2.12650740 |
| 29 | MP0008057_abnormal_DNA_replication | 2.06957920 |
| 30 | MP0002138_abnormal_hepatobiliary_system | 2.01848648 |
| 31 | MP0003868_abnormal_feces_composition | 1.88170405 |
| 32 | MP0005319_abnormal_enzyme/_coenzyme | 1.80501684 |
| 33 | MP0001764_abnormal_homeostasis | 1.77559306 |
| 34 | MP0000372_irregular_coat_pigmentation | 1.73085157 |
| 35 | MP0009697_abnormal_copulation | 1.71676086 |
| 36 | MP0005451_abnormal_body_composition | 1.60910548 |
| 37 | MP0005584_abnormal_enzyme/coenzyme_acti | 1.58805327 |
| 38 | MP0001730_embryonic_growth_arrest | 1.53055145 |
| 39 | MP0003011_delayed_dark_adaptation | 1.45130631 |
| 40 | MP0006072_abnormal_retinal_apoptosis | 1.41925095 |
| 41 | MP0004147_increased_porphyrin_level | 1.41616701 |
| 42 | MP0000358_abnormal_cell_content/ | 1.40072227 |
| 43 | MP0003186_abnormal_redox_activity | 1.37685688 |
| 44 | MP0005075_abnormal_melanosome_morpholog | 1.35500604 |
| 45 | MP0002938_white_spotting | 1.32926596 |
| 46 | MP0009643_abnormal_urine_homeostasis | 1.28055885 |
| 47 | MP0001293_anophthalmia | 1.26890098 |
| 48 | MP0002102_abnormal_ear_morphology | 1.24163808 |
| 49 | MP0003656_abnormal_erythrocyte_physiolo | 1.20579828 |
| 50 | MP0000350_abnormal_cell_proliferation | 1.19754774 |
| 51 | MP0003567_abnormal_fetal_cardiomyocyte | 1.19152658 |
| 52 | MP0010307_abnormal_tumor_latency | 1.15585460 |
| 53 | MP0000598_abnormal_liver_morphology | 1.14920655 |
| 54 | MP0005647_abnormal_sex_gland | 1.14655471 |
| 55 | MP0000313_abnormal_cell_death | 1.14256472 |
| 56 | MP0009764_decreased_sensitivity_to | 1.13993439 |
| 57 | MP0002090_abnormal_vision | 1.11693598 |
| 58 | MP0001929_abnormal_gametogenesis | 1.09328636 |
| 59 | MP0006292_abnormal_olfactory_placode | 1.08866336 |
| 60 | MP0002019_abnormal_tumor_incidence | 1.07692131 |
| 61 | MP0001697_abnormal_embryo_size | 1.06742097 |
| 62 | MP0000604_amyloidosis | 1.04065074 |
| 63 | MP0009763_increased_sensitivity_to | 1.03772183 |
| 64 | MP0010352_gastrointestinal_tract_polyps | 1.01349069 |
| 65 | MP0002080_prenatal_lethality | 1.00932567 |
| 66 | MP0008995_early_reproductive_senescence | 0.99423832 |
| 67 | MP0002254_reproductive_system_inflammat | 0.98815941 |
| 68 | MP0005636_abnormal_mineral_homeostasis | 0.95976536 |
| 69 | MP0005380_embryogenesis_phenotype | 0.95386405 |
| 70 | MP0001672_abnormal_embryogenesis/_devel | 0.95386405 |
| 71 | MP0003890_abnormal_embryonic-extraembry | 0.94098882 |
| 72 | MP0010368_abnormal_lymphatic_system | 0.92892030 |
| 73 | MP0002396_abnormal_hematopoietic_system | 0.92425104 |
| 74 | MP0008469_abnormal_protein_level | 0.92178691 |
| 75 | MP0003705_abnormal_hypodermis_morpholog | 0.90164896 |
| 76 | MP0009642_abnormal_blood_homeostasis | 0.87911491 |
| 77 | MP0002876_abnormal_thyroid_physiology | 0.87830072 |
| 78 | MP0005408_hypopigmentation | 0.85770286 |
| 79 | MP0005670_abnormal_white_adipose | 0.85725282 |
| 80 | MP0005084_abnormal_gallbladder_morpholo | 0.85029578 |
| 81 | MP0008789_abnormal_olfactory_epithelium | 0.83489014 |
| 82 | MP0006036_abnormal_mitochondrial_physio | 0.83467911 |
| 83 | MP0000653_abnormal_sex_gland | 0.83393390 |
| 84 | MP0009765_abnormal_xenobiotic_induced | 0.81995662 |
| 85 | MP0001145_abnormal_male_reproductive | 0.81743457 |
| 86 | MP0002210_abnormal_sex_determination | 0.81092013 |
| 87 | MP0005253_abnormal_eye_physiology | 0.80761101 |
| 88 | MP0001119_abnormal_female_reproductive | 0.80651394 |
| 89 | MP0002084_abnormal_developmental_patter | 0.80249089 |
| 90 | MP0005376_homeostasis/metabolism_phenot | 0.80148596 |
| 91 | MP0005367_renal/urinary_system_phenotyp | 0.78477141 |
| 92 | MP0000516_abnormal_urinary_system | 0.78477141 |
| 93 | MP0003690_abnormal_glial_cell | 0.77791290 |
| 94 | MP0002078_abnormal_glucose_homeostasis | 0.77773643 |
| 95 | MP0002971_abnormal_brown_adipose | 0.75387929 |
| 96 | MP0001529_abnormal_vocalization | 0.75320471 |
| 97 | MP0001661_extended_life_span | 0.74070103 |
| 98 | MP0002736_abnormal_nociception_after | 0.73924488 |
| 99 | MP0003984_embryonic_growth_retardation | 0.72040580 |
| 100 | MP0005334_abnormal_fat_pad | 0.71404214 |
| 101 | MP0002088_abnormal_embryonic_growth/wei | 0.70575585 |
| 102 | MP0002085_abnormal_embryonic_tissue | 0.70539484 |
| 103 | MP0005220_abnormal_exocrine_pancreas | 0.68839765 |
| 104 | MP0005535_abnormal_body_temperature | 0.68097734 |
| 105 | MP0004130_abnormal_muscle_cell | 0.67823816 |
| 106 | MP0002160_abnormal_reproductive_system | 0.65078173 |
| 107 | MP0001324_abnormal_eye_pigmentation | 0.64716550 |
| 108 | MP0001756_abnormal_urination | 0.63109199 |
| 109 | MP0009703_decreased_birth_body | 0.62826118 |
| 110 | MP0000639_abnormal_adrenal_gland | 0.62077267 |
| 111 | MP0005266_abnormal_metabolism | 0.61415334 |
| 112 | MP0000689_abnormal_spleen_morphology | 0.60645579 |
| 113 | MP0005464_abnormal_platelet_physiology | 0.59832957 |
| 114 | MP0001727_abnormal_embryo_implantation | 0.59693299 |
| 115 | MP0000647_abnormal_sebaceous_gland | 0.59365557 |
| 116 | MP0002638_abnormal_pupillary_reflex | 0.58237444 |
| 117 | MP0002233_abnormal_nose_morphology | 0.57123829 |
| 118 | MP0003724_increased_susceptibility_to | 0.56979417 |
| 119 | MP0006035_abnormal_mitochondrial_morpho | 0.55986388 |
| 120 | MP0005448_abnormal_energy_balance | 0.55640975 |
| 121 | MP0002086_abnormal_extraembryonic_tissu | 0.54363098 |
| 122 | MP0003329_amyloid_beta_deposits | 0.54050466 |
| 123 | MP0009053_abnormal_anal_canal | 0.52413029 |
| 124 | MP0004381_abnormal_hair_follicle | 0.52265303 |
| 125 | MP0002136_abnormal_kidney_physiology | 0.50940535 |
| 126 | MP0002928_abnormal_bile_duct | 0.49536353 |
| 127 | MP0005395_other_phenotype | 0.49118266 |
| 128 | MP0003638_abnormal_response/metabolism_ | 0.46160129 |
| 129 | MP0004782_abnormal_surfactant_physiolog | 0.45514501 |
| 130 | MP0003436_decreased_susceptibility_to | 0.45381010 |
| 131 | MP0003718_maternal_effect | 0.43909960 |
| 132 | MP0008874_decreased_physiological_sensi | 0.42983214 |
| 133 | MP0008873_increased_physiological_sensi | 0.42477638 |
| 134 | MP0006082_CNS_inflammation | 0.42465149 |
| 135 | MP0003953_abnormal_hormone_level | 0.41635113 |
| 136 | MP0005666_abnormal_adipose_tissue | 0.39887190 |
| 137 | MP0003075_altered_response_to | 0.38748144 |
| 138 | MP0001853_heart_inflammation | 0.37078407 |
| 139 | MP0000230_abnormal_systemic_arterial | 0.36774441 |
| 140 | MP0009115_abnormal_fat_cell | 0.36589804 |
| 141 | MP0002132_abnormal_respiratory_system | 0.35237630 |
| 142 | MP0005166_decreased_susceptibility_to | 0.35182702 |
| 143 | MP0005248_abnormal_Harderian_gland | 0.34988837 |
| 144 | MP0002822_catalepsy | 0.34318490 |
| 145 | MP0000249_abnormal_blood_vessel | 0.33853327 |
| 146 | MP0002168_other_aberrant_phenotype | 0.33697304 |
| 147 | MP0008872_abnormal_physiological_respon | 0.33225210 |
| 148 | MP0001243_abnormal_dermal_layer | 0.32637187 |
| 149 | MP0004883_abnormal_blood_vessel | 0.31900669 |
| 150 | MP0001845_abnormal_inflammatory_respons | 0.31268015 |
| 151 | MP0009672_abnormal_birth_weight | 0.30982736 |
| 152 | MP0002837_dystrophic_cardiac_calcinosis | 0.30827628 |
| 153 | MP0002970_abnormal_white_adipose | 0.30621211 |
| 154 | MP0000579_abnormal_nail_morphology | 0.29875828 |
| 155 | MP0009384_cardiac_valve_regurgitation | 0.29042703 |
| 156 | MP0001881_abnormal_mammary_gland | 0.26640526 |
| 157 | MP0005164_abnormal_response_to | 0.26449336 |
| 158 | MP0002796_impaired_skin_barrier | 0.26131709 |
| 159 | MP0005058_abnormal_lysosome_morphology | 0.23516109 |
| 160 | MP0000427_abnormal_hair_cycle | 0.23259211 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Abnormality of aromatic amino acid family metabolism (HP:0004338) | 7.32119818 |
| 2 | Intrahepatic cholestasis (HP:0001406) | 7.30964516 |
| 3 | Deep venous thrombosis (HP:0002625) | 7.19632678 |
| 4 | Abnormality of monocarboxylic acid metabolism (HP:0010996) | 6.57616666 |
| 5 | Prolonged partial thromboplastin time (HP:0003645) | 6.56725762 |
| 6 | Hypobetalipoproteinemia (HP:0003563) | 6.34575960 |
| 7 | Xanthomatosis (HP:0000991) | 6.25537392 |
| 8 | Hyperlipoproteinemia (HP:0010980) | 5.58395047 |
| 9 | Complement deficiency (HP:0004431) | 5.01552316 |
| 10 | Joint hemorrhage (HP:0005261) | 4.86915015 |
| 11 | Hypolipoproteinemia (HP:0010981) | 4.72115034 |
| 12 | Hyperammonemia (HP:0001987) | 4.63019894 |
| 13 | Epidermoid cyst (HP:0200040) | 4.52179895 |
| 14 | Hyperglycinemia (HP:0002154) | 4.48431408 |
| 15 | Abnormality of methionine metabolism (HP:0010901) | 4.39839364 |
| 16 | Abnormality of the common coagulation pathway (HP:0010990) | 4.38567166 |
| 17 | Abnormality of the level of lipoprotein cholesterol (HP:0010979) | 4.36966532 |
| 18 | Ketosis (HP:0001946) | 4.28471915 |
| 19 | Abnormality of sulfur amino acid metabolism (HP:0004339) | 4.27991958 |
| 20 | Abnormality of aspartate family amino acid metabolism (HP:0010899) | 4.26171862 |
| 21 | Abnormality of glutamine family amino acid metabolism (HP:0010902) | 4.17319528 |
| 22 | Fat malabsorption (HP:0002630) | 4.11758799 |
| 23 | Hyperglycinuria (HP:0003108) | 4.11690416 |
| 24 | Hypoalphalipoproteinemia (HP:0003233) | 4.11144328 |
| 25 | Abnormality of glycine metabolism (HP:0010895) | 4.06984306 |
| 26 | Abnormality of serine family amino acid metabolism (HP:0010894) | 4.06984306 |
| 27 | Hypoglycemic coma (HP:0001325) | 3.99466692 |
| 28 | Abnormality of pyrimidine metabolism (HP:0004353) | 3.90591441 |
| 29 | Conjugated hyperbilirubinemia (HP:0002908) | 3.78913895 |
| 30 | Abnormality of the intrinsic pathway (HP:0010989) | 3.71104329 |
| 31 | Acute encephalopathy (HP:0006846) | 3.69406179 |
| 32 | Abnormality of complement system (HP:0005339) | 3.65345558 |
| 33 | Hypercholesterolemia (HP:0003124) | 3.60882639 |
| 34 | Acute necrotizing encephalopathy (HP:0006965) | 3.49881658 |
| 35 | Abnormality of fatty-acid metabolism (HP:0004359) | 3.49065346 |
| 36 | Abnormality of long-chain fatty-acid metabolism (HP:0010964) | 3.41229660 |
| 37 | Hyperbilirubinemia (HP:0002904) | 3.39022434 |
| 38 | Reduced antithrombin III activity (HP:0001976) | 3.30415898 |
| 39 | Type I transferrin isoform profile (HP:0003642) | 3.29520526 |
| 40 | Abnormal mitochondria in muscle tissue (HP:0008316) | 3.27553273 |
| 41 | Abnormality of the labia minora (HP:0012880) | 3.25102878 |
| 42 | Increased CSF lactate (HP:0002490) | 3.23670061 |
| 43 | Delayed CNS myelination (HP:0002188) | 3.18422177 |
| 44 | Abnormality of serum amino acid levels (HP:0003112) | 3.16634102 |
| 45 | Steatorrhea (HP:0002570) | 3.12974947 |
| 46 | Ketoacidosis (HP:0001993) | 3.09741573 |
| 47 | Abnormality of nucleobase metabolism (HP:0010932) | 3.09266759 |
| 48 | Mitochondrial inheritance (HP:0001427) | 3.07366291 |
| 49 | Spontaneous abortion (HP:0005268) | 2.96490011 |
| 50 | Abnormality of alanine metabolism (HP:0010916) | 2.96350719 |
| 51 | Hyperalaninemia (HP:0003348) | 2.96350719 |
| 52 | Abnormality of pyruvate family amino acid metabolism (HP:0010915) | 2.96350719 |
| 53 | Abnormal isoelectric focusing of serum transferrin (HP:0003160) | 2.95794809 |
| 54 | Abnormal protein N-linked glycosylation (HP:0012347) | 2.95794809 |
| 55 | Abnormal protein glycosylation (HP:0012346) | 2.95794809 |
| 56 | Abnormal glycosylation (HP:0012345) | 2.95794809 |
| 57 | Colon cancer (HP:0003003) | 2.94958130 |
| 58 | Hepatocellular carcinoma (HP:0001402) | 2.94129954 |
| 59 | Increased serum pyruvate (HP:0003542) | 2.92571684 |
| 60 | Myocardial infarction (HP:0001658) | 2.90368067 |
| 61 | Lipid accumulation in hepatocytes (HP:0006561) | 2.90181663 |
| 62 | Progressive macrocephaly (HP:0004481) | 2.86199690 |
| 63 | Hepatic necrosis (HP:0002605) | 2.84909767 |
| 64 | Metabolic acidosis (HP:0001942) | 2.84776425 |
| 65 | Chromsome breakage (HP:0040012) | 2.83563806 |
| 66 | Chromosomal breakage induced by crosslinking agents (HP:0003221) | 2.81741281 |
| 67 | Abnormality of glycolysis (HP:0004366) | 2.79558568 |
| 68 | Hypochromic microcytic anemia (HP:0004840) | 2.79329968 |
| 69 | Hepatocellular necrosis (HP:0001404) | 2.77433509 |
| 70 | Abnormality of dicarboxylic acid metabolism (HP:0010995) | 2.77272067 |
| 71 | Dicarboxylic aciduria (HP:0003215) | 2.77272067 |
| 72 | Increased serum lactate (HP:0002151) | 2.70290532 |
| 73 | Skin nodule (HP:0200036) | 2.69989283 |
| 74 | Lethargy (HP:0001254) | 2.69493400 |
| 75 | Abnormality of purine metabolism (HP:0004352) | 2.68604417 |
| 76 | Vascular calcification (HP:0004934) | 2.66560251 |
| 77 | Microvesicular hepatic steatosis (HP:0001414) | 2.64204676 |
| 78 | Increased hepatocellular lipid droplets (HP:0006565) | 2.64091496 |
| 79 | Lactic acidosis (HP:0003128) | 2.63607203 |
| 80 | Hypoglycemic seizures (HP:0002173) | 2.63095146 |
| 81 | Systemic lupus erythematosus (HP:0002725) | 2.61125018 |
| 82 | Acanthocytosis (HP:0001927) | 2.59312362 |
| 83 | Abnormality of chromosome stability (HP:0003220) | 2.51454475 |
| 84 | Pancreatic islet-cell hyperplasia (HP:0004510) | 2.51067854 |
| 85 | Cerebral edema (HP:0002181) | 2.50077215 |
| 86 | Glomerulonephritis (HP:0000099) | 2.48845304 |
| 87 | Methylmalonic acidemia (HP:0002912) | 2.48564680 |
| 88 | Gout (HP:0001997) | 2.39472254 |
| 89 | Abnormal gallbladder morphology (HP:0012437) | 2.39440454 |
| 90 | Mitral stenosis (HP:0001718) | 2.37878453 |
| 91 | Gonadotropin excess (HP:0000837) | 2.35557605 |
| 92 | Cardiovascular calcification (HP:0011915) | 2.35369926 |
| 93 | Meckel diverticulum (HP:0002245) | 2.34951115 |
| 94 | Irritability (HP:0000737) | 2.34219277 |
| 95 | Spastic diplegia (HP:0001264) | 2.33990176 |
| 96 | Ependymoma (HP:0002888) | 2.30386837 |
| 97 | Gingival bleeding (HP:0000225) | 2.29591337 |
| 98 | Abnormal activity of mitochondrial respiratory chain (HP:0011922) | 2.28644351 |
| 99 | Decreased activity of mitochondrial respiratory chain (HP:0008972) | 2.28644351 |
| 100 | Generalized aminoaciduria (HP:0002909) | 2.28412555 |
| 101 | Cholelithiasis (HP:0001081) | 2.28317017 |
| 102 | Posterior subcapsular cataract (HP:0007787) | 2.28281008 |
| 103 | Hypoplastic pelvis (HP:0008839) | 2.27646863 |
| 104 | Amyloidosis (HP:0011034) | 2.27051696 |
| 105 | Methylmalonic aciduria (HP:0012120) | 2.26827463 |
| 106 | Malnutrition (HP:0004395) | 2.23772392 |
| 107 | Abnormality of the ileum (HP:0001549) | 2.23076667 |
| 108 | Neonatal onset (HP:0003623) | 2.22870959 |
| 109 | Enlarged kidneys (HP:0000105) | 2.22632716 |
| 110 | Pancytopenia (HP:0001876) | 2.21644144 |
| 111 | Abnormal lung lobation (HP:0002101) | 2.21057571 |
| 112 | Abnormality of the preputium (HP:0100587) | 2.20802581 |
| 113 | Pancreatitis (HP:0001733) | 2.20473687 |
| 114 | Menorrhagia (HP:0000132) | 2.17272572 |
| 115 | Renal Fanconi syndrome (HP:0001994) | 2.16970962 |
| 116 | Renal cortical cysts (HP:0000803) | 2.16658430 |
| 117 | Recurrent gram-negative bacterial infections (HP:0005420) | 2.16033790 |
| 118 | Vomiting (HP:0002013) | 2.14274791 |
| 119 | Brushfield spots (HP:0001088) | 2.14004727 |
| 120 | Abnormal gallbladder physiology (HP:0012438) | 2.13649687 |
| 121 | Cholecystitis (HP:0001082) | 2.13649687 |
| 122 | Birth length less than 3rd percentile (HP:0003561) | 2.11320989 |
| 123 | IgM deficiency (HP:0002850) | 2.10333196 |
| 124 | Esophageal varix (HP:0002040) | 2.10183986 |
| 125 | Multiple enchondromatosis (HP:0005701) | 2.09820209 |
| 126 | Thrombophlebitis (HP:0004418) | 2.07903214 |
| 127 | Opisthotonus (HP:0002179) | 2.07872462 |
| 128 | Sensorimotor neuropathy (HP:0007141) | 2.07675623 |
| 129 | Megaloblastic anemia (HP:0001889) | 2.07547898 |
| 130 | 3-Methylglutaconic aciduria (HP:0003535) | 2.07513623 |
| 131 | Increased intramyocellular lipid droplets (HP:0012240) | 2.07467174 |
| 132 | Aplasia/Hypoplasia of the uvula (HP:0010293) | 2.06538962 |
| 133 | Late onset (HP:0003584) | 2.04442063 |
| 134 | Hyperinsulinemic hypoglycemia (HP:0000825) | 2.04090854 |
| 135 | CNS demyelination (HP:0007305) | 2.01807393 |
| 136 | Reticulocytopenia (HP:0001896) | 2.00688048 |
| 137 | Increased muscle lipid content (HP:0009058) | 1.99948673 |
| 138 | Rickets (HP:0002748) | 1.99624049 |
| 139 | Poikilocytosis (HP:0004447) | 1.98745111 |
| 140 | Neoplasm of the adrenal gland (HP:0100631) | 1.98463244 |
| 141 | Exercise intolerance (HP:0003546) | 1.97807224 |
| 142 | Hemorrhage of the eye (HP:0011885) | 1.97657223 |
| 143 | Degeneration of anterior horn cells (HP:0002398) | 1.96747213 |
| 144 | Abnormality of the anterior horn cell (HP:0006802) | 1.96747213 |
| 145 | Alkalosis (HP:0001948) | 1.95978861 |
| 146 | Horseshoe kidney (HP:0000085) | 1.95726437 |
| 147 | Abnormal biliary tract physiology (HP:0012439) | 1.95096308 |
| 148 | Bile duct proliferation (HP:0001408) | 1.95096308 |
| 149 | Abnormality of the gallbladder (HP:0005264) | 1.93969911 |
| 150 | Respiratory failure (HP:0002878) | 1.93962341 |
| 151 | Myelodysplasia (HP:0002863) | 1.93676155 |
| 152 | Elevated hepatic transaminases (HP:0002910) | 1.92128924 |
| 153 | Proximal tubulopathy (HP:0000114) | 1.92107105 |
| 154 | Hydroxyprolinuria (HP:0003080) | 1.90820700 |
| 155 | Abnormality of proline metabolism (HP:0010907) | 1.90820700 |
| 156 | Leukodystrophy (HP:0002415) | 1.87790352 |
| 157 | Hypophosphatemic rickets (HP:0004912) | 1.86837818 |
| 158 | Nausea (HP:0002018) | 1.86560911 |
| 159 | Abnormality of the duodenum (HP:0002246) | 1.86210317 |
| 160 | Abnormality of iron homeostasis (HP:0011031) | 1.85908598 |
| 161 | Duodenal stenosis (HP:0100867) | 1.85613814 |
| 162 | Small intestinal stenosis (HP:0012848) | 1.85613814 |
| 163 | Sloping forehead (HP:0000340) | 1.85306761 |
| 164 | Abnormal enzyme/coenzyme activity (HP:0012379) | 1.84336923 |
| 165 | Abnormal spermatogenesis (HP:0008669) | 1.83424863 |
| 166 | Abnormality of transition element cation homeostasis (HP:0011030) | 1.81431811 |
| 167 | Neoplasm of the colon (HP:0100273) | 1.81196459 |
| 168 | Abnormality of urine glucose concentration (HP:0011016) | 1.80966985 |
| 169 | Glycosuria (HP:0003076) | 1.80966985 |
| 170 | Abnormality of vitamin metabolism (HP:0100508) | 1.80557094 |
| 171 | Abnormal cartilage morphology (HP:0002763) | 1.80271406 |
| 172 | Nephroblastoma (Wilms tumor) (HP:0002667) | 1.79827779 |
| 173 | Carpal bone hypoplasia (HP:0001498) | 1.77393238 |
| 174 | Aplastic anemia (HP:0001915) | 1.76773062 |
| 175 | Combined immunodeficiency (HP:0005387) | 1.76010056 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | BCKDK | 7.43893659 |
| 2 | SIK1 | 4.51755689 |
| 3 | FGFR4 | 4.35529989 |
| 4 | BUB1 | 4.34651777 |
| 5 | ERN1 | 3.73439325 |
| 6 | INSRR | 3.39127210 |
| 7 | TAOK3 | 3.00292560 |
| 8 | MST4 | 2.98841109 |
| 9 | EIF2AK1 | 2.97318803 |
| 10 | VRK2 | 2.92163362 |
| 11 | ZAK | 2.90549063 |
| 12 | SRPK1 | 2.81199373 |
| 13 | EIF2AK3 | 2.74834043 |
| 14 | ERBB4 | 2.67864431 |
| 15 | TTK | 2.67466783 |
| 16 | PDK2 | 2.58599575 |
| 17 | CDC7 | 2.56282663 |
| 18 | NEK1 | 2.37884488 |
| 19 | TSSK6 | 2.33697163 |
| 20 | FLT3 | 2.20512276 |
| 21 | PLK3 | 2.18320910 |
| 22 | BRSK2 | 2.17228702 |
| 23 | PIK3CG | 2.10988190 |
| 24 | PKN2 | 2.07443276 |
| 25 | TRIM28 | 2.00797711 |
| 26 | MST1R | 1.97338583 |
| 27 | MAP2K4 | 1.93860115 |
| 28 | MAPK11 | 1.85102135 |
| 29 | TYK2 | 1.84135803 |
| 30 | VRK1 | 1.80027626 |
| 31 | PLK4 | 1.77889440 |
| 32 | MKNK1 | 1.77007996 |
| 33 | MAP4K2 | 1.68336918 |
| 34 | MKNK2 | 1.66702118 |
| 35 | WEE1 | 1.60222890 |
| 36 | NME1 | 1.50646001 |
| 37 | TNIK | 1.49609268 |
| 38 | NEK9 | 1.46727542 |
| 39 | MAP3K14 | 1.45547952 |
| 40 | LATS1 | 1.43629270 |
| 41 | WNK3 | 1.43556162 |
| 42 | DAPK2 | 1.43002404 |
| 43 | ABL2 | 1.40404001 |
| 44 | PLK1 | 1.38882024 |
| 45 | PINK1 | 1.35650294 |
| 46 | EIF2AK2 | 1.34190085 |
| 47 | FGFR2 | 1.33455280 |
| 48 | IRAK3 | 1.30819130 |
| 49 | KDR | 1.30691633 |
| 50 | FRK | 1.28252453 |
| 51 | PRKAA2 | 1.24694943 |
| 52 | PTK6 | 1.23665496 |
| 53 | JAK2 | 1.15624527 |
| 54 | BMPR1B | 1.15572036 |
| 55 | TIE1 | 1.15431497 |
| 56 | TBK1 | 1.14555910 |
| 57 | TRIB3 | 1.13726856 |
| 58 | ACVR1B | 1.13537098 |
| 59 | NME2 | 1.12495819 |
| 60 | EPHB1 | 1.11351122 |
| 61 | JAK1 | 1.10749330 |
| 62 | ATR | 1.10432309 |
| 63 | TAF1 | 1.09394396 |
| 64 | MAP3K7 | 1.05190566 |
| 65 | AURKB | 1.03969382 |
| 66 | MAP3K12 | 1.01996771 |
| 67 | MAPK15 | 0.99682707 |
| 68 | STK38L | 0.98715979 |
| 69 | MAPK4 | 0.98703812 |
| 70 | SCYL2 | 0.94123764 |
| 71 | RPS6KA4 | 0.93503484 |
| 72 | MAP2K3 | 0.92041586 |
| 73 | ERBB3 | 0.91993685 |
| 74 | ERBB2 | 0.88623420 |
| 75 | BRSK1 | 0.88388594 |
| 76 | CHEK2 | 0.85493118 |
| 77 | GRK6 | 0.83171047 |
| 78 | MET | 0.81817591 |
| 79 | CSNK1A1L | 0.81567437 |
| 80 | MAPK12 | 0.80668498 |
| 81 | CAMK1D | 0.80473792 |
| 82 | IKBKE | 0.80343158 |
| 83 | GRK1 | 0.80017053 |
| 84 | PRKCZ | 0.79555172 |
| 85 | BCR | 0.77843739 |
| 86 | EPHA3 | 0.77659188 |
| 87 | STK4 | 0.77467889 |
| 88 | CSK | 0.76480812 |
| 89 | SGK3 | 0.75259230 |
| 90 | CSNK1G2 | 0.74891905 |
| 91 | CSF1R | 0.74454526 |
| 92 | PRKACG | 0.73295559 |
| 93 | ATM | 0.73065215 |
| 94 | PASK | 0.72667692 |
| 95 | OXSR1 | 0.71084987 |
| 96 | SGK2 | 0.70801919 |
| 97 | CHEK1 | 0.70595839 |
| 98 | PBK | 0.70487624 |
| 99 | MAPK7 | 0.68333248 |
| 100 | GSK3A | 0.67881337 |
| 101 | ALK | 0.67816934 |
| 102 | CDK19 | 0.67058788 |
| 103 | CDK6 | 0.66771931 |
| 104 | TGFBR2 | 0.66337831 |
| 105 | PRKCQ | 0.66046407 |
| 106 | MAP2K6 | 0.65601646 |
| 107 | CAMK2G | 0.65314657 |
| 108 | MAP3K3 | 0.65261034 |
| 109 | PRKAA1 | 0.64906709 |
| 110 | DAPK1 | 0.64293633 |
| 111 | TESK2 | 0.63264051 |
| 112 | DYRK1B | 0.62007028 |
| 113 | PLK2 | 0.61446487 |
| 114 | RPS6KB2 | 0.61224770 |
| 115 | STK3 | 0.60832733 |
| 116 | SGK494 | 0.60382372 |
| 117 | SGK223 | 0.60382372 |
| 118 | IRAK1 | 0.60119312 |
| 119 | PAK4 | 0.59951541 |
| 120 | TLK1 | 0.59142846 |
| 121 | CCNB1 | 0.58367539 |
| 122 | MAP3K4 | 0.58228676 |
| 123 | CSNK2A2 | 0.57750677 |
| 124 | CLK1 | 0.57339141 |
| 125 | CSNK2A1 | 0.56208699 |
| 126 | IRAK2 | 0.54787806 |
| 127 | FGFR3 | 0.54729385 |
| 128 | PKN1 | 0.53980733 |
| 129 | IGF1R | 0.50781801 |
| 130 | CSNK1G1 | 0.49810089 |
| 131 | STK10 | 0.49736415 |
| 132 | TXK | 0.49381094 |
| 133 | PRKCI | 0.49364354 |
| 134 | MAP3K11 | 0.48666179 |
| 135 | AURKA | 0.48141693 |
| 136 | RPS6KA5 | 0.47805717 |
| 137 | TAOK2 | 0.44406460 |
| 138 | NUAK1 | 0.44296628 |
| 139 | PDPK1 | 0.43053774 |
| 140 | MAP3K10 | 0.42154736 |
| 141 | PIM1 | 0.38948727 |
| 142 | CDK7 | 0.37386481 |
| 143 | KIT | 0.35679252 |
| 144 | BMPR2 | 0.34961340 |
| 145 | STK39 | 0.34592757 |
| 146 | MAP3K8 | 0.34331339 |
| 147 | PTK2 | 0.34140512 |
| 148 | BTK | 0.31591732 |
| 149 | CDK1 | 0.31154919 |
| 150 | DYRK3 | 0.30860118 |
| 151 | NEK2 | 0.30593278 |
| 152 | DYRK2 | 0.30030407 |
| 153 | PDK1 | 0.29869860 |
| 154 | ITK | 0.29817751 |
| 155 | MAP3K13 | 0.29444990 |
| 156 | IRAK4 | 0.29354210 |
| 157 | PRKCG | 0.29130993 |
| 158 | CAMK4 | 0.28770080 |
| 159 | CDK2 | 0.28318143 |
| 160 | MAP4K1 | 0.28254126 |
| 161 | IKBKB | 0.28246858 |
| 162 | EPHA4 | 0.27887511 |
| 163 | PRKCA | 0.27200095 |
| 164 | STK16 | 0.27000674 |
| 165 | MAP3K5 | 0.26849187 |
| 166 | BRD4 | 0.26769000 |
| 167 | NLK | 0.26691832 |
| 168 | PDK3 | 0.26495989 |
| 169 | PDK4 | 0.26495989 |
| 170 | CHUK | 0.26351967 |
| 171 | PIK3CA | 0.26318978 |
| 172 | CSNK1E | 0.25514768 |
| 173 | MAP3K6 | 0.25416768 |
| 174 | CSNK1G3 | 0.24828355 |
| 175 | ABL1 | 0.24554179 |
| 176 | AKT3 | 0.24517875 |
| 177 | EGFR | 0.24222136 |
| 178 | RAF1 | 0.24076117 |
| 179 | PRKDC | 0.23611046 |
| 180 | SIK3 | 0.21862579 |
| 181 | PAK1 | 0.21545790 |
| 182 | BRAF | 0.21366451 |
| 183 | TEC | 0.20222832 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 4.41497384 |
| 2 | Proteasome_Homo sapiens_hsa03050 | 3.70067074 |
| 3 | Nitrogen metabolism_Homo sapiens_hsa00910 | 3.45900323 |
| 4 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 3.38025980 |
| 5 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 3.12184268 |
| 6 | Arginine biosynthesis_Homo sapiens_hsa00220 | 2.90955126 |
| 7 | Mismatch repair_Homo sapiens_hsa03430 | 2.88534155 |
| 8 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 2.80692446 |
| 9 | DNA replication_Homo sapiens_hsa03030 | 2.74580699 |
| 10 | Non-homologous end-joining_Homo sapiens_hsa03450 | 2.71189362 |
| 11 | Tryptophan metabolism_Homo sapiens_hsa00380 | 2.67856930 |
| 12 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 2.66669146 |
| 13 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 2.60401186 |
| 14 | Ribosome biogenesis in eukaryotes_Homo sapiens_hsa03008 | 2.56989008 |
| 15 | Fatty acid degradation_Homo sapiens_hsa00071 | 2.55159137 |
| 16 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 2.52063963 |
| 17 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 2.46953808 |
| 18 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 2.31526467 |
| 19 | Butanoate metabolism_Homo sapiens_hsa00650 | 2.19532688 |
| 20 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 2.18561942 |
| 21 | RNA polymerase_Homo sapiens_hsa03020 | 2.18436824 |
| 22 | Homologous recombination_Homo sapiens_hsa03440 | 2.11762269 |
| 23 | Aminoacyl-tRNA biosynthesis_Homo sapiens_hsa00970 | 2.11009804 |
| 24 | * Peroxisome_Homo sapiens_hsa04146 | 2.11003279 |
| 25 | Propanoate metabolism_Homo sapiens_hsa00640 | 2.05914780 |
| 26 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 1.99436893 |
| 27 | Base excision repair_Homo sapiens_hsa03410 | 1.97817404 |
| 28 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 1.97583815 |
| 29 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 1.96715478 |
| 30 | Histidine metabolism_Homo sapiens_hsa00340 | 1.92862033 |
| 31 | PPAR signaling pathway_Homo sapiens_hsa03320 | 1.89749891 |
| 32 | Fatty acid metabolism_Homo sapiens_hsa01212 | 1.89510583 |
| 33 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 1.79362627 |
| 34 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 1.78843075 |
| 35 | Retinol metabolism_Homo sapiens_hsa00830 | 1.75157593 |
| 36 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 1.74857520 |
| 37 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 1.72392021 |
| 38 | Protein export_Homo sapiens_hsa03060 | 1.71252537 |
| 39 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 1.70493433 |
| 40 | Nucleotide excision repair_Homo sapiens_hsa03420 | 1.69323114 |
| 41 | RNA transport_Homo sapiens_hsa03013 | 1.67925334 |
| 42 | Caffeine metabolism_Homo sapiens_hsa00232 | 1.65861869 |
| 43 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 1.65479469 |
| 44 | Oxidative phosphorylation_Homo sapiens_hsa00190 | 1.58276552 |
| 45 | Selenocompound metabolism_Homo sapiens_hsa00450 | 1.56119005 |
| 46 | Parkinsons disease_Homo sapiens_hsa05012 | 1.54675190 |
| 47 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 1.53692365 |
| 48 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 1.53112418 |
| 49 | Spliceosome_Homo sapiens_hsa03040 | 1.51943314 |
| 50 | Fatty acid elongation_Homo sapiens_hsa00062 | 1.51632118 |
| 51 | Fanconi anemia pathway_Homo sapiens_hsa03460 | 1.50321765 |
| 52 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 1.44790540 |
| 53 | Ribosome_Homo sapiens_hsa03010 | 1.44298967 |
| 54 | RNA degradation_Homo sapiens_hsa03018 | 1.44142720 |
| 55 | Bile secretion_Homo sapiens_hsa04976 | 1.42885542 |
| 56 | Pyrimidine metabolism_Homo sapiens_hsa00240 | 1.42861396 |
| 57 | Tyrosine metabolism_Homo sapiens_hsa00350 | 1.42180347 |
| 58 | Sulfur metabolism_Homo sapiens_hsa00920 | 1.40398140 |
| 59 | Pyruvate metabolism_Homo sapiens_hsa00620 | 1.37430558 |
| 60 | Steroid biosynthesis_Homo sapiens_hsa00100 | 1.36848386 |
| 61 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 1.29247292 |
| 62 | Cysteine and methionine metabolism_Homo sapiens_hsa00270 | 1.26751876 |
| 63 | Basal transcription factors_Homo sapiens_hsa03022 | 1.24883609 |
| 64 | ABC transporters_Homo sapiens_hsa02010 | 1.23832058 |
| 65 | Folate biosynthesis_Homo sapiens_hsa00790 | 1.22640880 |
| 66 | Cell cycle_Homo sapiens_hsa04110 | 1.13345625 |
| 67 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 1.12384172 |
| 68 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 1.12293885 |
| 69 | Carbon metabolism_Homo sapiens_hsa01200 | 1.11183718 |
| 70 | Fat digestion and absorption_Homo sapiens_hsa04975 | 1.09719621 |
| 71 | Purine metabolism_Homo sapiens_hsa00230 | 1.08197822 |
| 72 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 1.04511503 |
| 73 | Huntingtons disease_Homo sapiens_hsa05016 | 1.02523733 |
| 74 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 0.98869341 |
| 75 | Vitamin B6 metabolism_Homo sapiens_hsa00750 | 0.97357928 |
| 76 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 0.96578149 |
| 77 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 0.96180350 |
| 78 | Vitamin digestion and absorption_Homo sapiens_hsa04977 | 0.93783120 |
| 79 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.92843358 |
| 80 | Sulfur relay system_Homo sapiens_hsa04122 | 0.90682074 |
| 81 | Lysine degradation_Homo sapiens_hsa00310 | 0.81432874 |
| 82 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 0.78788518 |
| 83 | One carbon pool by folate_Homo sapiens_hsa00670 | 0.76867654 |
| 84 | Alzheimers disease_Homo sapiens_hsa05010 | 0.72189831 |
| 85 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 0.69253820 |
| 86 | Glutathione metabolism_Homo sapiens_hsa00480 | 0.68695494 |
| 87 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 0.66002216 |
| 88 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 0.65988493 |
| 89 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 0.61102684 |
| 90 | p53 signaling pathway_Homo sapiens_hsa04115 | 0.58652954 |
| 91 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 0.57926710 |
| 92 | Metabolic pathways_Homo sapiens_hsa01100 | 0.49437444 |
| 93 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 0.47028357 |
| 94 | N-Glycan biosynthesis_Homo sapiens_hsa00510 | 0.45918087 |
| 95 | mRNA surveillance pathway_Homo sapiens_hsa03015 | 0.45622472 |
| 96 | Oocyte meiosis_Homo sapiens_hsa04114 | 0.37127817 |
| 97 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 0.36841980 |
| 98 | Ubiquitin mediated proteolysis_Homo sapiens_hsa04120 | 0.35757305 |
| 99 | Terpenoid backbone biosynthesis_Homo sapiens_hsa00900 | 0.32913214 |
| 100 | Primary immunodeficiency_Homo sapiens_hsa05340 | 0.31479732 |
| 101 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 0.29931454 |
| 102 | Galactose metabolism_Homo sapiens_hsa00052 | 0.26889000 |
| 103 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 0.24741568 |
| 104 | Epstein-Barr virus infection_Homo sapiens_hsa05169 | 0.24463320 |
| 105 | Prion diseases_Homo sapiens_hsa05020 | 0.23726681 |
| 106 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 0.22170929 |
| 107 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.21612640 |
| 108 | Insulin resistance_Homo sapiens_hsa04931 | 0.19271666 |
| 109 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 0.17224869 |
| 110 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.15905681 |
| 111 | Glucagon signaling pathway_Homo sapiens_hsa04922 | 0.05541438 |
| 112 | Glycosylphosphatidylinositol(GPI)-anchor biosynthesis_Homo sapiens_hsa00563 | -0.2648138 |
| 113 | Protein processing in endoplasmic reticulum_Homo sapiens_hsa04141 | -0.2566175 |
| 114 | Pertussis_Homo sapiens_hsa05133 | -0.2482973 |
| 115 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | -0.2470898 |
| 116 | Thyroid hormone synthesis_Homo sapiens_hsa04918 | -0.2368666 |
| 117 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | -0.2308353 |
| 118 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | -0.2239067 |
| 119 | Central carbon metabolism in cancer_Homo sapiens_hsa05230 | -0.2193853 |
| 120 | Renin-angiotensin system_Homo sapiens_hsa04614 | -0.1735419 |
| 121 | Hepatitis C_Homo sapiens_hsa05160 | -0.1679716 |
| 122 | Ether lipid metabolism_Homo sapiens_hsa00565 | -0.1655261 |
| 123 | Systemic lupus erythematosus_Homo sapiens_hsa05322 | -0.1652316 |
| 124 | African trypanosomiasis_Homo sapiens_hsa05143 | -0.1528984 |
| 125 | Glycosaminoglycan biosynthesis - heparan sulfate / heparin_Homo sapiens_hsa00534 | -0.1520765 |
| 126 | Insulin signaling pathway_Homo sapiens_hsa04910 | -0.1447132 |
| 127 | Regulation of autophagy_Homo sapiens_hsa04140 | -0.1251427 |
| 128 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | -0.1176105 |
| 129 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | -0.0724679 |
| 130 | Ovarian steroidogenesis_Homo sapiens_hsa04913 | -0.0509482 |
| 131 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | -0.0495369 |
| 132 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | -0.0159785 |
| 133 | AMPK signaling pathway_Homo sapiens_hsa04152 | -0.0101577 |

